CBS Lunchtime Webinar on Thursday, April 10th - Dr. Darcy Wagner
0 comments
by Patricia Comeau
Dear CBS members, Greetings The Montreal Student Chapter of the Canadian Biomaterials Society is thrilled to invite you to a CBS Lunchtime webinar series talk and a lab tour on April 10th This event will feature an online presentation by Professor Darcy Wagner from McGill University at noon and an in-person lab tour starting at 4 30pm meet at RI-MUHC, Bloc E Atrium ...
A special CBS2025 opportunity for ECR faculty members!
0 comments
by Lindsay Fitzpatrick
Calling all ECR Faculty Members for Keynote Presentation Opportunities Dear CBS Members, A feature of CBS2025 will be presentations from current Early Career Researcher ECR faculty member highlighting their expertise and new research...
CBS2025 Final Abstract Submission Deadline Extension
0 comments
by
CBS2025 abstract submission deadline is extended until February 7th We know it is a busy time of year and so we are happy to announce that the CBS 2025 abstract submission deadline for the 39th Annual Meeting of the Canadian Biomaterial Society has been extended until February 7th, 2025 please note that this will be the last extension The CBS2025 Organizing Committee invites you to submit your abstracts related to biomaterials research through the Oxford Abstracts submission portal...
A Thermoresponsive Composite Hydrogel with pH dependent H2S Release Capabilities for Dental Pulp Stem Cells Capsulated for Local Treatment of Spinal Cord Injury
comments
Natural tissues nanomechanical mapping is useful in providing an in depth knowledge about the detailed microstructure and the mechanical features of the materials...
Cardiovascular diseases continue to be the leading cause of death worldwide. Among these disorders, coronary stenosis is a major threat because it can directly cause heart muscle tissue death and heart arrest...
Tumor resection, trauma, and infection are a few of the conditions that may lead to bone loss. Oftentimes, the body requires additional medical intervention to aid in its natural regeneration process due to the extent of bone loss...
Doxorubicin is widespread and influential apoptosis-inducing drug in cancer chemotherapy which interdicts DNA replication and treats different types of cancers including, benign, potentially-malignant, glioblastoma malignant tumours 1 2 3 ...
